Lisiane Pruinelli1, Bonnie L Westra1,2, Pranjul Yadav3, Alexander Hoff3, Michael Steinbach3, Vipin Kumar3, Connie W Delaney1,2, Gyorgy Simon2,4. 1. Population Health and Systems, University of Minnesota, School of Nursing, Minneapolis, MN. 2. University of Minnesota, Institute for Health Informatics, Minneapolis, MN. 3. Department of Computer Science and Engineering, University of Minnesota, Minneapolis, MN. 4. Department of Medicine, University of Minnesota, School of Medicine, Minneapolis, MN.
Abstract
OBJECTIVES: To specify when delays of specific 3-hour bundle Surviving Sepsis Campaign guideline recommendations applied to severe sepsis or septic shock become harmful and impact mortality. DESIGN: Retrospective cohort study. SETTING: One health system composed of six hospitals and 45 clinics in a Midwest state from January 01, 2011, to July 31, 2015. PATIENTS: All adult patients hospitalized with billing diagnosis of severe sepsis or septic shock. INTERVENTIONS: Four 3-hour Surviving Sepsis Campaign guideline recommendations: 1) obtain blood culture before antibiotics, 2) obtain lactate level, 3) administer broad-spectrum antibiotics, and 4) administer 30 mL/kg of crystalloid fluid for hypotension (defined as "mean arterial pressure" < 65) or lactate (> 4). MEASUREMENTS AND MAIN RESULTS: To determine the effect of t minutes of delay in carrying out each intervention, propensity score matching of "baseline" characteristics compensated for differences in health status. The average treatment effect in the treated computed as the average difference in outcomes between those treated after shorter versus longer delay. To estimate the uncertainty associated with the average treatment effect in the treated metric and to construct 95% CIs, bootstrap estimation with 1,000 replications was performed. From 5,072 patients with severe sepsis or septic shock, 1,412 (27.8%) had in-hospital mortality. The majority of patients had the four 3-hour bundle recommendations initiated within 3 hours. The statistically significant time in minutes after which a delay increased the risk of death for each recommendation was as follows: lactate, 20.0 minutes; blood culture, 50.0 minutes; crystalloids, 100.0 minutes; and antibiotic therapy, 125.0 minutes. CONCLUSIONS: The guideline recommendations showed that shorter delays indicates better outcomes. There was no evidence that 3 hours is safe; even very short delays adversely impact outcomes. Findings demonstrated a new approach to incorporate time t when analyzing the impact on outcomes and provide new evidence for clinical practice and research.
OBJECTIVES: To specify when delays of specific 3-hour bundle Surviving Sepsis Campaign guideline recommendations applied to severe sepsis or septic shock become harmful and impact mortality. DESIGN: Retrospective cohort study. SETTING: One health system composed of six hospitals and 45 clinics in a Midwest state from January 01, 2011, to July 31, 2015. PATIENTS: All adult patients hospitalized with billing diagnosis of severe sepsis or septic shock. INTERVENTIONS: Four 3-hour Surviving Sepsis Campaign guideline recommendations: 1) obtain blood culture before antibiotics, 2) obtain lactate level, 3) administer broad-spectrum antibiotics, and 4) administer 30 mL/kg of crystalloid fluid for hypotension (defined as "mean arterial pressure" < 65) or lactate (> 4). MEASUREMENTS AND MAIN RESULTS: To determine the effect of t minutes of delay in carrying out each intervention, propensity score matching of "baseline" characteristics compensated for differences in health status. The average treatment effect in the treated computed as the average difference in outcomes between those treated after shorter versus longer delay. To estimate the uncertainty associated with the average treatment effect in the treated metric and to construct 95% CIs, bootstrap estimation with 1,000 replications was performed. From 5,072 patients with severe sepsis or septic shock, 1,412 (27.8%) had in-hospital mortality. The majority of patients had the four 3-hour bundle recommendations initiated within 3 hours. The statistically significant time in minutes after which a delay increased the risk of death for each recommendation was as follows: lactate, 20.0 minutes; blood culture, 50.0 minutes; crystalloids, 100.0 minutes; and antibiotic therapy, 125.0 minutes. CONCLUSIONS: The guideline recommendations showed that shorter delays indicates better outcomes. There was no evidence that 3 hours is safe; even very short delays adversely impact outcomes. Findings demonstrated a new approach to incorporate time t when analyzing the impact on outcomes and provide new evidence for clinical practice and research.
Authors: Craig A Umscheid; Joel Betesh; Christine VanZandbergen; Asaf Hanish; Gordon Tait; Mark E Mikkelsen; Benjamin French; Barry D Fuchs Journal: J Hosp Med Date: 2014-09-26 Impact factor: 2.960
Authors: Eren Gultepe; Jeffrey P Green; Hien Nguyen; Jason Adams; Timothy Albertson; Ilias Tagkopoulos Journal: J Am Med Inform Assoc Date: 2013-08-19 Impact factor: 4.497
Authors: Sameer S Kadri; Chanu Rhee; Jeffrey R Strich; Megan K Morales; Samuel Hohmann; Jonathan Menchaca; Anthony F Suffredini; Robert L Danner; Michael Klompas Journal: Chest Date: 2016-07-22 Impact factor: 9.410
Authors: D C Angus; A E Barnato; D Bell; R Bellomo; C-R Chong; T J Coats; A Davies; A Delaney; D A Harrison; A Holdgate; B Howe; D T Huang; T Iwashyna; J A Kellum; S L Peake; F Pike; M C Reade; K M Rowan; M Singer; S A R Webb; L A Weissfeld; D M Yealy; J D Young Journal: Intensive Care Med Date: 2015-05-08 Impact factor: 17.440
Authors: Lisiane Pruinelli; Pranjul Yadav; Andrew Hangsleben; Jakob Johnson; Sanjoy Dey; Maribet McCarty; Vipin Kumar; Connie W Delaney; Michael Steinbach; Bonnie L Westra; György J Simon Journal: AMIA Jt Summits Transl Sci Proc Date: 2016-07-20
Authors: Thomas Desautels; Jacob Calvert; Jana Hoffman; Melissa Jay; Yaniv Kerem; Lisa Shieh; David Shimabukuro; Uli Chettipally; Mitchell D Feldman; Chris Barton; David J Wales; Ritankar Das Journal: JMIR Med Inform Date: 2016-09-30
Authors: Daniel E Leisman; Catalina Angel; Sandra M Schneider; Jason A D'Amore; John K D'Angelo; Martin E Doerfler Journal: J Hosp Med Date: 2019-04-08 Impact factor: 2.960
Authors: Chanu Rhee; Michael R Filbin; Anthony F Massaro; Amy L Bulger; Donna McEachern; Kathleen A Tobin; Barrett T Kitch; Bert Thurlo-Walsh; Aran Kadar; Alexandra Koffman; Anupam Pande; Yasir Hamad; David K Warren; Travis M Jones; Cara O'Brien; Deverick J Anderson; Rui Wang; Michael Klompas Journal: Crit Care Med Date: 2018-10 Impact factor: 7.598
Authors: Taalin R Hoj; Bradley McNeely; Kylie Webber; Evelyn Welling; William G Pitt; Larry C Ford; Richard A Robison Journal: J Med Microbiol Date: 2021-12 Impact factor: 2.472
Authors: F J Candel; M Borges Sá; S Belda; G Bou; J L Del Pozo; O Estrada; R Ferrer; J González Del Castillo; A Julián-Jiménez; I Martín-Loeches; E Maseda; M Matesanz; P Ramírez; J T Ramos; J Rello; B Suberviola; A Suárez de la Rica; P Vidal Journal: Rev Esp Quimioter Date: 2018-06-25 Impact factor: 1.553